Table 1 Occasional relapses of SU during the 4-year period of follow-up and required treatment
From: Long term treatment with omalizumab in adolescent with refractory solar urticaria
Cycle 1 | Cycle 2 | Cycle 3 | Cycle 4 | |
|---|---|---|---|---|
Number of flares | 0 | 2 | 0 | 2 |
Clinical manifestations | – | Erythema/Mild itch | – | Erythema, hives, angioedema/mild itch |
Treatment description | – | Rupatadine (10 mg/day for 14 days) | – | Rupatadine (10 mg/day for 7 days) Bilastine (20 mg/day for 7 days) |
Remission interval after last administration (months) | 4 | 3 | 1 | 4 |